newsfilter
← Latest News
PR Newswire·

Acasti Pharma to Participate in Oppenheimer 33rd Annual Healthcare Conference

LAVAL, QC, March 8, 2023 /PRNewswire/ -- Acasti Pharma Inc. ("Acasti" or the "Company") (NASDAQ:ACST, TSXV:ACST), a late-stage, specialty pharma company advancing three clinical stage drug candidates